238 related articles for article (PubMed ID: 28515448)
21. Impact of β-glycerophosphate on the bioenergetic profile of vascular smooth muscle cells.
Alesutan I; Moritz F; Haider T; Shouxuan S; Gollmann-Tepeköylü C; Holfeld J; Pieske B; Lang F; Eckardt KU; Heinzmann SS; Voelkl J
J Mol Med (Berl); 2020 Jul; 98(7):985-997. PubMed ID: 32488546
[TBL] [Abstract][Full Text] [Related]
22. Oxidative stress by Ca
Nguyen NT; Nguyen TT; Da Ly D; Xia JB; Qi XF; Lee IK; Cha SK; Park KS
Am J Physiol Heart Circ Physiol; 2020 Dec; 319(6):H1302-H1312. PubMed ID: 33095057
[TBL] [Abstract][Full Text] [Related]
23. Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury.
Luther JM; Luo P; Wang Z; Cohen SE; Kim HS; Fogo AB; Brown NJ
Kidney Int; 2012 Sep; 82(6):643-51. PubMed ID: 22622494
[TBL] [Abstract][Full Text] [Related]
24. TDAG51 (T-Cell Death-Associated Gene 51) Is a Key Modulator of Vascular Calcification and Osteogenic Transdifferentiation of Arterial Smooth Muscle Cells.
Platko K; Lebeau PF; Gyulay G; Lhoták Š; MacDonald ME; Pacher G; Hyun Byun J; Boivin FJ; Igdoura SA; Cutz JC; Bridgewater D; Ingram AJ; Krepinsky JC; Austin RC
Arterioscler Thromb Vasc Biol; 2020 Jul; 40(7):1664-1679. PubMed ID: 32434409
[TBL] [Abstract][Full Text] [Related]
25. High phosphate-induced downregulation of PPARγ contributes to CKD-associated vascular calcification.
Liu L; Liu Y; Zhang Y; Bi X; Nie L; Liu C; Xiong J; He T; Xu X; Yu Y; Yang K; Gu J; Huang Y; Zhang J; Zhang Z; Zhang B; Zhao J
J Mol Cell Cardiol; 2018 Jan; 114():264-275. PubMed ID: 29197521
[TBL] [Abstract][Full Text] [Related]
26. p53 negatively regulates the osteogenic differentiation of vascular smooth muscle cells in mice with chronic kidney disease.
Li KL; Chen J; Li ZH; Zhao L; He YN
Cardiovasc J Afr; 2012 Jul; 23(6):e1-9. PubMed ID: 22143460
[TBL] [Abstract][Full Text] [Related]
27. Biotransformation of the mineralocorticoid receptor antagonists spironolactone and canrenone by human CYP11B1 and CYP11B2: Characterization of the products and their influence on mineralocorticoid receptor transactivation.
Schiffer L; Müller AR; Hobler A; Brixius-Anderko S; Zapp J; Hannemann F; Bernhardt R
J Steroid Biochem Mol Biol; 2016 Oct; 163():68-76. PubMed ID: 27125452
[TBL] [Abstract][Full Text] [Related]
28. Adipocyte-derived factors regulate vascular smooth muscle cells through mineralocorticoid and glucocorticoid receptors.
Nguyen Dinh Cat A; Briones AM; Callera GE; Yogi A; He Y; Montezano AC; Touyz RM
Hypertension; 2011 Sep; 58(3):479-88. PubMed ID: 21788604
[TBL] [Abstract][Full Text] [Related]
29. Spironolactone dose‑dependently alleviates the calcification of aortic rings cultured in hyperphosphatemic medium with or without hyperglycemia by suppressing phenotypic transition of VSMCs through downregulation of Pit‑1.
Wang P; Quan Z; Luo D; Chen W; Peng D
Mol Med Rep; 2019 May; 19(5):3622-3632. PubMed ID: 30896801
[TBL] [Abstract][Full Text] [Related]
30. Mineralocorticoid receptor activation promotes vascular cell calcification.
Jaffe IZ; Tintut Y; Newfell BG; Demer LL; Mendelsohn ME
Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):799-805. PubMed ID: 17234727
[TBL] [Abstract][Full Text] [Related]
31. A novel role for the mineralocorticoid receptor in glucocorticoid driven vascular calcification.
Zhu D; Rashdan NA; Chapman KE; Hadoke PW; MacRae VE
Vascul Pharmacol; 2016 Nov; 86():87-93. PubMed ID: 27153999
[TBL] [Abstract][Full Text] [Related]
32. Spironolactone ameliorates arterial medial calcification in uremic rats: the role of mineralocorticoid receptor signaling in vascular calcification.
Tatsumoto N; Yamada S; Tokumoto M; Eriguchi M; Noguchi H; Torisu K; Tsuruya K; Kitazono T
Am J Physiol Renal Physiol; 2015 Dec; 309(11):F967-79. PubMed ID: 26336165
[TBL] [Abstract][Full Text] [Related]
33. Sodium-dependent phosphate cotransporters and phosphate-induced calcification of vascular smooth muscle cells: redundant roles for PiT-1 and PiT-2.
Crouthamel MH; Lau WL; Leaf EM; Chavkin NW; Wallingford MC; Peterson DF; Li X; Liu Y; Chin MT; Levi M; Giachelli CM
Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2625-32. PubMed ID: 23968976
[TBL] [Abstract][Full Text] [Related]
34. Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency.
Jimbo R; Kawakami-Mori F; Mu S; Hirohama D; Majtan B; Shimizu Y; Yatomi Y; Fukumoto S; Fujita T; Shimosawa T
Kidney Int; 2014 May; 85(5):1103-11. PubMed ID: 24088960
[TBL] [Abstract][Full Text] [Related]
35. Upregulated LncRNA H19 Sponges MiR-106a-5p and Contributes to Aldosterone-Induced Vascular Calcification via Activating the Runx2-Dependent Pathway.
Li XZ; Xiong ZC; Zhang SL; Hao QY; Liu ZY; Zhang HF; Wang JF; Gao JW; Liu PM
Arterioscler Thromb Vasc Biol; 2023 Sep; 43(9):1684-1699. PubMed ID: 37409531
[TBL] [Abstract][Full Text] [Related]
36. Stanniocalcin 2 is associated with ectopic calcification in α-klotho mutant mice and inhibits hyperphosphatemia-induced calcification in aortic vascular smooth muscle cells.
Takei Y; Yamamoto H; Sato T; Otani A; Kozai M; Masuda M; Taketani Y; Muto-Sato K; Lanske B; Takeda E
Bone; 2012 Apr; 50(4):998-1005. PubMed ID: 22285620
[TBL] [Abstract][Full Text] [Related]
37. Inorganic phosphate accelerates the migration of vascular smooth muscle cells: evidence for the involvement of miR-223.
Rangrez AY; M'Baya-Moutoula E; Metzinger-Le Meuth V; Hénaut L; Djelouat MS; Benchitrit J; Massy ZA; Metzinger L
PLoS One; 2012; 7(10):e47807. PubMed ID: 23094093
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of c1q/tumor necrosis factor-related protein-3 promotes phosphate-induced vascular smooth muscle cell calcification both in vivo and in vitro.
Zhou Y; Wang JY; Feng H; Wang C; Li L; Wu D; Lei H; Li H; Wu LL
Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1002-10. PubMed ID: 24578384
[TBL] [Abstract][Full Text] [Related]
39. WNT/β-catenin signaling promotes VSMCs to osteogenic transdifferentiation and calcification through directly modulating Runx2 gene expression.
Cai T; Sun D; Duan Y; Wen P; Dai C; Yang J; He W
Exp Cell Res; 2016 Jul; 345(2):206-17. PubMed ID: 27321958
[TBL] [Abstract][Full Text] [Related]
40. Zinc Ameliorates the Osteogenic Effects of High Glucose in Vascular Smooth Muscle Cells.
Henze LA; Estepa M; Pieske B; Lang F; Eckardt KU; Alesutan I; Voelkl J
Cells; 2021 Nov; 10(11):. PubMed ID: 34831306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
